- Home
- FLGC vs BOLT Comparison
FLGC vs BOLT Comparison
Compare FLGC & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGC
- BOLT
- Stock Information
- Founded
- FLGC 2019
- BOLT 2015
- Country
- FLGC United States
- BOLT United States
- Employees
- FLGC N/A
- BOLT N/A
- Industry
- FLGC Biotechnology: Pharmaceutical Preparations
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- FLGC Health Care
- BOLT Health Care
- Exchange
- FLGC Nasdaq
- BOLT Nasdaq
- Market Cap
- FLGC 15.9M
- BOLT 16.8M
- IPO Year
- FLGC 2021
- BOLT 2021
- Fundamental
- Price
- FLGC $0.69
- BOLT $6.19
- Analyst Decision
- FLGC Buy
- BOLT Buy
- Analyst Count
- FLGC 2
- BOLT 3
- Target Price
- FLGC $4.00
- BOLT $50.00
- AVG Volume (30 Days)
- FLGC 116.7K
- BOLT 18.8K
- Earning Date
- FLGC 08-11-2025
- BOLT 08-12-2025
- Dividend Yield
- FLGC N/A
- BOLT N/A
- EPS Growth
- FLGC N/A
- BOLT N/A
- EPS
- FLGC N/A
- BOLT N/A
- Revenue
- FLGC $53,260,000.00
- BOLT $3,638,000.00
- Revenue This Year
- FLGC N/A
- BOLT N/A
- Revenue Next Year
- FLGC N/A
- BOLT $24.14
- P/E Ratio
- FLGC N/A
- BOLT N/A
- Revenue Growth
- FLGC N/A
- BOLT N/A
- 52 Week Low
- FLGC $0.42
- BOLT $5.20
- 52 Week High
- FLGC $2.11
- BOLT $15.60
- Technical
- Relative Strength Index (RSI)
- FLGC 55.93
- BOLT 52.70
- Support Level
- FLGC $0.62
- BOLT $5.68
- Resistance Level
- FLGC $0.72
- BOLT $6.40
- Average True Range (ATR)
- FLGC 0.05
- BOLT 0.30
- MACD
- FLGC 0.00
- BOLT 0.09
- Stochastic Oscillator
- FLGC 75.00
- BOLT 79.81
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.